Dow Up 0.26% Nasdaq Down 1.07%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
2.51 0.01(0.40%) Sep 15, 4:01PM EDT
Prev Close:2.50
Open:2.45
Bid:2.46 x 1900
Ask:2.48 x 500
1y Target Est:5.50
Beta:1.4
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.45 - 2.52
52wk Range:2.35 - 5.30
Volume:214,213
Avg Vol (3m):371,439
Market Cap:232.98M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PLX

Comparison

Symbol% ChgMkt Cap
PLXUp 0.40%232.98M
SHPG50.17B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.21
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback